Zentalis Pharmaceuticals
ZNTL
ZNTL
120 hedge funds and large institutions have $2.1B invested in Zentalis Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more capital invested
Capital invested by funds: $1.58B → $2.1B (+$527M)
26% more funds holding
Funds holding: 95 → 120 (+25)
8.44% more ownership
Funds ownership: 88.52% → 96.96% (+8.4%)
Holders
120
Holding in Top 10
4
Calls
$5.39M
Puts
$969K
Top Buyers
| 1 | +$116M | |
| 2 | +$47.7M | |
| 3 | +$26.9M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$26.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.1M |
Top Sellers
| 1 | -$95.5M | |
| 2 | -$21.9M | |
| 3 | -$14.2M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.75M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$7.6M |